Consensus Ocugen, Inc. Börse Stuttgart

Equities

2H51

US67577C1053

Real-time Estimate Tradegate 07:11:31 17/07/2024 pm IST 5-day change 1st Jan Change
1.732 EUR -1.70% Intraday chart for Ocugen, Inc. +7.50% +220.95%

Evolution of the average Target Price on Ocugen, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7482214.BiRTiOXqDVHHCoYSnrhLP6dy3xb7RUUaCTJy5LiSgi0.agkA56KnbBqWfcNjze4uZt8rui_LIzZ7a14Wkvvb1B5lUGXZg6hiFqVh0w~3efa31f772c1e741bd7760d3ac5e1bbc
Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating MT
Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on Ocugen to $7 From $5, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Ocugen's Price Target to $2 From $2.50, Keeps Overweight Rating MT
Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept MT
Chardan Upgrades Ocugen to Buy From Neutral, Citing Recent Sell-Off MT
Mizuho Adjusts Price Target on Ocugen to $3 From $5, Maintains Buy Rating MT
Mizuho Securities Starts Ocugen at Buy With $5 Price Target MT
HC Wainwright Adjusts Ocugen's Price Target to $6 from $7, Maintains Buy Rating MT
Roth Capital Reinstates Ocugen at Buy with $8 Price Target MT
Cantor Fitzgerald Starts Ocugen at Overweight With $4.50 Price Target MT
Chardan Trims Ocugen's Price Targe to $3.50 From $4, Maintains Neutral Rating MT
Chardan Research Adjusts Ocugen's Price Target to $3.50 From $4, Maintains Neutral Rating MT
HC Wainwright Adjusts Ocugen's Price Target to $8 from $10, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : Alliant Energy, Ally Financial, Alphabet, HSBC, Honest... Our Logo
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $4 From $11, Maintains Neutral Rating MT
OCUGEN : Chardan Adjusts Ocugen PT to $4.50 From $8, Maintains Neutral Rating MT
OCUGEN : HC Wainwright Adjusts Ocugen's Price Target to $10 From $12, Maintains Buy Rating MT
OCUGEN : Roth Capital Cuts Ocugen to Neutral From Buy, Price Target to $6 From $10 MT
OCUGEN : Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating MT
TODAY'S ANALYST RECOMMENDATIONS : Oracle, Facebook, Berkeley, Acushnet, Ocugen, London Stock Exchange, Flutter... Our Logo
OCUGEN : Cantor Fitzgerald Downgrades Ocugen to Neutral From Overweight, Adjusts PT to $11 From $15 MT
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $15 From $4, Maintains Overweight Rating MT
OCUGEN : Chardan Capital Downgrades Ocugen to Neutral From Buy on Valuation, Adjusts Price Target to $13 From $0.70 MT
OCUGEN : HC Wainwright Upgrades Ocugen to Buy From Neutral; Price Target is $4.50 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.95 USD
Average target price
6.667 USD
Spread / Average Target
+241.88%
High Price Target
8 USD
Spread / Highest target
+310.26%
Low Price Target
5 USD
Spread / Lowest Target
+156.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ocugen, Inc.

Chardan Research
HC Wainwright
Cantor Fitzgerald
Mizuho Securities
Roth Capital Partners
Chardan
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings